Blog

Pharma giant Eli Lilly acquires Cambridge startup Disarm Therapeutics

jeffreymilbrandt900xx1198-800-0-0

The company is developing treatments for neurologic diseases like ALS, Parkinson’s and multiple sclerosis.

Read More